AI generated summary of Pubmed citation/abstract with PMID 38092897

https://pubmed.ncbi.nlm.nih.gov/38092897

The K(Ca)2 potassium channel inhibitor AP30663 showed promising efficacy in converting recent-onset atrial fibrillation to sinus rhythm in a phase 2 trial, with a good safety profile.